Evan Schnell
InvestorVenture Partner at Kaleida Capital
Find your path to Evan
Sign up to see every warm intro you have to Evan
- Paths you didn't know you had: your email and LinkedIn already hold routes to Evan. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Evan Schnell is a Venture Partner at Kaleida Capital with over 25 years building and commercializing clinical-grade software across brain-computer interfaces, neuromodulation, and healthcare infrastructure. He is currently Director of Medical Device Software at Axoft and was previously Senior Director of Software at Synchron, and earlier a Principal Software Engineer at Medtronic contributing to the Percept DBS system, with prior roles at McKesson and RelayHealth. He holds an MBA from the University of Minnesota Carlson School of Management and advises Kaleida on NeuroAI, BCI, and regulated digital health.
Invests in
AI & Machine LearningDigital HealthHealthtechMedical Devices
Colleagues at Kaleida Capital
Frequently asked questions
- Who is Evan Schnell?
- Evan Schnell is a Venture Partner at Kaleida Capital with over 25 years building and commercializing clinical-grade software across brain-computer interfaces, neuromodulation, and healthcare infrastructure. He is currently Director of Medical Device Software at Axoft and was previously Senior Director of Software at Synchron, and earlier a Principal Software Engineer at Medtronic contributing to the Percept DBS system, with prior roles at McKesson and RelayHealth. He holds an MBA from the University of Minnesota Carlson School of Management and advises Kaleida on NeuroAI, BCI, and regulated digital health.
- Where does Evan Schnell work?
- Evan Schnell is Venture Partner at Kaleida Capital.
- What does Evan Schnell invest in?
- Evan Schnell invests in AI & Machine Learning, Digital Health, Healthtech, Medical Devices.
About this profile. Compiled from public sources — Kaleida Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights







